ArticleJournal of medicinal chemistry2025

Structure-Based Design and Optimization Lead to the Identification of a Novel Potent sEH Inhibitor with PPARγ Partial Agonist Activity against Inflammatory and Metabolic-Related Diseases.

Ruolin Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.